EurekaMag.com logo
+ Translate

Zinc distribution in blood components, inflammatory status, and clinical indexes of disease activity during zinc supplementation in inflammatory rheumatic diseases


, : Zinc distribution in blood components, inflammatory status, and clinical indexes of disease activity during zinc supplementation in inflammatory rheumatic diseases. American Journal of Clinical Nutrition 57(5): 690-694

The effects of zinc supplementation on zinc status and on clinical and biological indicators of inflammation were investigated in 18 patients with chronic inflammatory rheumatic diseases and in 9 healthy control subjects. Patients with mild and recent onset disease were assigned to a 60-d trial to receive either 45 mg Zn (as gluconate)/d or a placebo, while control subjects received the zinc supplement. Baseline mean plasma zinc of the patients was low whereas mononuclear cell zinc content was elevated, suggesting a redistribution of the element related to the inflammatory process rather than to a zinc-deficient state. Zinc supplementation increased plasma zinc to a similar extent in patients and in control subjects, which suggested no impairment of zinc intestinal absorption as a result of the inflammatory process. On the contrary, erythrocyte and leukocyte zinc concentrations were not modified in the two groups examined. No beneficial effect of zinc treatment could be demonstrated on either clinical or inflammation indexes.

(PDF 0-2 workdays service)

Accession: 002549134

PMID: 8480688

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Peretz, A.; Cantinieaux, B.; Nève, J.; Siderova, V.; Fondu, P., 1994: Effects of zinc supplementation on the phagocytic functions of polymorphonuclears in patients with inflammatory rheumatic diseases. The phagocytosis of blood polymorphonuclear cells (PMNs) was measured by cytofluorometry in 22 patients with inflammatory rheumatic diseases before and after a 60-day treatment with 45 mg zinc daily or a placebo, and the values were compared with...

Sharif, R.; Thomas, P.; Zalewski, P.; Fenech, M., 2016: Zinc supplementation influences genomic stability biomarkers, antioxidant activity, and zinc transporter genes in an elderly Australian population with low zinc status. An increased intake of Zinc (Zn) may reduce the risk of degenerative diseases but may prove to be toxic if taken in excess. This study aimed to investigate whether zinc carnosine supplement can improve Zn status, genome stability events, and Zn tr...

Peretz A.; Neve J.; Famaey J.P., 1988: Zinc copper and selenium in chronic and acute inflammatory rheumatic diseases. Braetter, P And P Schramel (Ed ) Trace Element Analytical Chemistry in Medicine And Biology Proceedings Of International Workshop, Vol 5; Neuherberg, West Germany, April Xix+666p Walter De Gruyter And Co : Berlin, West Germany; Hawthorne, New York, Usa Illus 471-476

Giacconi, R.; Costarelli, L.; Malavolta, M.; Cardelli, M.; Galeazzi, R.; Piacenza, F.; Gasparini, N.; Basso, A.; Mariani, E.; Fulop, T.; Rink, L.; Dedoussis, G.; Herbein, G.; Jajte, J.; Provinciali, M.; Busco, F.; Mocchegiani, E., 2016: Effect of ZIP2 Gln/Arg/Leu (rs2234632) polymorphism on zinc homeostasis and inflammatory response following zinc supplementation. Zinc dyshomeostasis may lead to an augmented production of proinflammatory cytokines promoting chronic inflammation and increasing the susceptibility to age-related diseases. Several studies suggest that the zinc transporter protein ZIP2 may play...

O.N.on, J.V.; Atkin Thor, E.; Rothert, S.W.; Stephen, R.L.; Goddard, B.W.; Ogilvie, S., 1978: Effect of zinc supplementation on red blood cell zinc, serum zinc, taste acuity, and dietary intake in zinc deficient dialysis patients. Of 30 chronic haemodialysis patients who had had no Zn supplement for 2 months, 25 were zinc-deficient at the start of the study. The patients were randomly assigned to a study of double-blind cross-over design, so at completion each patient had r...

Ainley, C.C.; Cason, J.; Carlsson, L.K.; Slavin, B.M.; Thompson, R.P., 1988: Zinc status in inflammatory bowel disease. 1. The zinc contents of plasma, erythrocytes, polymorphonuclear leucocytes and mononuclear leucocytes from 18 normal control subjects, 31 patients with Crohn's disease and 15 patients with ulcerative colitis were measured. 2. Plasma zinc leve...

Kremer, Joel M., 1996: Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids. To describe the rationale and status of n-3 and n-6 fatty acid dietary supplementation in patients with inflammatory disease. The most recent literature is reviewed with a focus on rheumatoid arthritis (RA) as most investigations have described th...

Bui, V.Q.; Marcinkevage, J.; Ramakrishnan, U.; Flores-Ayala, R.C.; Ramirez-Zea, M.; Villalpando, S.; Martorell, R.; DiGirolamo, A.M.; Stein, A.D., 2013: Associations among dietary zinc intakes and biomarkers of zinc status before and after a zinc supplementation program in Guatemalan schoolchildren. The associations among dietary zinc intakes and biomarkers of zinc status are unknown in apparently healthy children at high risk for zinc deficiency. To assess associations among zinc-related parameters in a sample of Guatemalan school-aged child...

Milne, D.; Wallwork, J.; Ralston, N., 1985: Analysis of zinc in blood cellular components as a means of assessment of zinc status. Trace elements in man and animals: TEMA 5: proceedings of the fifth International Symposium on Trace Elements in Man and Animals editors CF Mills I Bremner and JK Chesters: 594

Krebs N.F.; Reidinger C.; Westcott J.L.; Hartley S.; Hambidge K.M., 1991: The effect of zinc supplementation during lactation on maternal zinc status and milk zinc concentrations. FASEB Journal 5(5): A1289